This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Grazziutti ML, Dong L, Miceli MH, Krishna SG, Kiwan E, Syed N et al. Oral mucositis in myeloma patients undergoing melphalan-based stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant 2006; 38: 501–506.
Nath CE, Shaw PJ, Montgomery K, Earl JW . Melphalan pharmacokinetics in children with malignant disease: influence of body weight, renal function, carboplatin therapy and total body irradiation. Br J Clin Pharmacol 2004; 59: 314–324.
Levey AS, Greene T, Kusek JW, Beck GJ . A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
Ploin DY, Tranchard B, Guastalla JP, Rebattu P, Chauvin F, Clavel M et al. Pharmacokinetically guided dosing for intravenous melphalan: a pilot study in patients with advanced ovarian adenocarcinoma. Eur J Cancer 1992; 28: 1311–1315.
Vassal G, Tranchard B, Valteau-Couanet D, Mahe C, Couanet D, Schoeppfer C et al. Pharmacodynamics of tandem high-dose melphalan with peripheral blood stem cell transplantation in children with neuroblastoma and medulloblastoma. Bone Marrow Transplant 2001; 27: 471–477.
Acknowledgements
CE Nath is supported by the Leukaemia Research Support Fund of The Children's Hospital Westmead, and by NH and MRC Project Grant 396702. L Zeng is also supported by NH and MRC Project Grant 396702. We thank the patients who are taking part in this study, the specialists who treat the patients and the nurses who collect the blood samples for melphalan concentration analysis.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nath, C., Shaw, P., Trotman, J. et al. Pharmacokinetics of melphalan in myeloma patients undergoing an autograft. Bone Marrow Transplant 40, 707–708 (2007). https://doi.org/10.1038/sj.bmt.1705797
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705797
This article is cited by
-
Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma
Bone Marrow Transplantation (2019)
-
Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation
Supportive Care in Cancer (2009)